Efficacy of tixagevimab-cilgavimab in preventing SARS-CoV-2 for patients with B-cell malignancies
Year: 2022
Type: article
Source: Blood
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Keywords: tixagevimab/cilgavimab, SARS-CoV-2, COVID-19 prevention, B-cell malignancies, chronic lymphocytic leukemia, B-cell lymphoma, multiple myeloma, B-cell acute lymphoblastic leukemia, pre-exposure prophylaxis, passive immunization, breakthrough infection, immunosuppression, COVID-19 vaccination
Open Access status: bronze
OpenAlex ID: W4308339823
